Magazine Article | October 10, 2017

Why South Korea Is The Hottest Growth Spot For Clinical Trials

Source: Life Science Leader

By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical

For any pharma company, the success of a study can often depend on selecting the right country in which to conduct a trial. Clinical experience, government regulation, and an accessible patient population are just a few factors that must be considered.

One country that has recently experienced astounding growth in this area is South Korea. The country’s mix of clinical experience, infrastructure, population density (50 million, with 25 percent concentrated in the Seoul metropolitan area), and a supportive government has boosted it into the top 10 locations worldwide to conduct a clinical study.